News Releases

Jul 03, 2008	Evotec's EVT 101 Well Tolerated in Four Week Higher Repeat Dose Safety Study
Jun 23, 2008	Evotec to Present at the Piper Jaffray Third Annual Europe Conference in London
May 08, 2008	Evotec Reports First Quarter 2008 Results
May 05, 2008	Evotec Completes Acquisition of Renovis
May 02, 2008	Evotec Completes Acquisition of Renovis
May 01, 2008	Renovis Stockholders Approve Acquisition by Evotec
Mar 28, 2008	Evotec's EVT 101 Shown to Penetrate the Brain in Man and to Modulate Brain Activity during the Performance of Cognitive Tasks
Mar 28, 2008	Evotec Announces Financial Results for 2007
Mar 27, 2008	Ono Enters into a New Fragment-Based Drug Discovery Agreement with Evotec
Mar 26, 2008	Evotec's Registration Statement in Connection with its Proposed Acquisition of Renovis Declared Effective
Mar 20, 2008	Evotec AG: Fiscal Year 2007 Results Presentation on March 28, 2008 Live on the Internet
Mar 14, 2008	Evotec to Present at the Cowen and Company 28th Annual Health Care Conference in Boston
Mar 12, 2008	Spermatech Selects Evotec as Partner for High-Throughput Screening and Lead Discovery
Mar 06, 2008	Evotec Expands Collaboration with InterMune
Feb 28, 2008	Evotec Starts Phase II in Smoking Cessation with EVT 302
Feb 14, 2008	Evotec Extends Ongoing Collaboration With CHDI Worth up to US$ 37 Million
Feb 08, 2008	Evotec to Present at the BIO CEO & Investor Conference 2008 in New York
Jan 07, 2008	Phase I Safety and Tolerability Study with EVT 302 Successfully Completed
Jan 07, 2008	Evotec Provides Update on Planned NASDAQ Listing in the Context of its Announced Acquisition of Renovis